| Literature DB >> 26840870 |
Abstract
Status epilepticus represents an acute, potentially life-threatening emergency with considerable risks of morbidity and mortality, mainly depending on age at onset, underlying etiology, seizure severity, and medical comorbidities. Recent European and North American guidelines on management and treatment of status epilepticus strongly recommend prompt treatment to prevent further complications. At present, following a staged treatment protocol is recommended. Benzodiazepines are the treatment of choice in early status epilepticus, but there are no class I data supporting treatment recommendations on the choice of antiepileptic drugs for established and refractory status epilepticus. This article reviews advantages and potential drawbacks of the available guidelines.Entities:
Mesh:
Substances:
Year: 2016 PMID: 26840870 DOI: 10.1097/WNP.0000000000000222
Source DB: PubMed Journal: J Clin Neurophysiol ISSN: 0736-0258 Impact factor: 2.177